Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

SETB. 2010; 44(2): 72-75

Two years mortality in patients with myocardial infarction in our center that can not be done interventional therapy

Fatma Alibaz Öner, Mecdi Ergüney, Mustafa Kemal Arslantaş.

Objective: The study was aimed to examine clinical and demographic characteristics, in-hospital and two years mortality of 92 patients hospitalized for acute myocardial infarction (MI) between January 2005-December 2005 in our hospital that can not made invasive therapy.

Methods: Records of patients were reviewed retrospectively. Two years moratlitiy was taken about by calling phone. For statistical evaluations, SPSS 16.0 for Windows software was used.

Results: Mean age of 92 patients was 58.1±10.14 years. Seventy-three of the patients were male and 19 were female. Non-ST elevation MI was found in 8 (9%) patients and ST-elevation MI in 84 (91%). Forty one (4%%) patients received thrombolytic treatment , 51 (65%) did not due to reaching to the hospital lately or several counter indication. Seventeen patients died at admission. In-hospital mortality rate is significantly lower in patients receiving thrombolitic (p=0.045). Thirty-three patients developed complication at admission. The most frequent complication was cardiogenic shock. In two years after discharcing th patients; two years moratlity was significantly lower in patients receiving thrombolitic (p

Key words: Myocardial infarction, thrombolytic, mortality

Article Language: Turkish English

Similar Articles

Long non-coding RNA MEG3 regulates autophagy after cerebral ischemia/reperfusion injury.
Li TH, Sun HW, Song LJ, Yang B, Zhang P, Yan DM, Liu XZ, Luo YR
Neural regeneration research. 2022; 17(4): 824-831

Encapsulation of lyophilized platelet-rich fibrin in alginate-hyaluronic acid hydrogel as a novel vascularized substitution for myocardial infarction.
Qian B, Yang Q, Wang M, Huang S, Jiang C, Shi H, Long Q, Zhou M, Zhao Q, Ye X
Bioactive materials. 2022; 7(): 401-411

Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries.
Zhao T, Wu W, Sui L, Huang Q, Nan Y, Liu J, Ai K
Bioactive materials. 2022; 7(): 47-72

Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.
Yang HS, Hur M, Lee KR, Kim H, Kim HY, Kim JW, Chua MT, Kuan WS, Chua HR, Kitiyakara C, Phattharapornjaroen P, Chittamma A, Werayachankul T, Anandh U, Herath S, Endre Z, Horvath AR, Antonini P, Somma SD,
Annals of laboratory medicine. 2022; 42(2): 178-187

Corrigendum to 'The circular RNA TLK1 exacerbates myocardial ischemia/reperfusion injury via targeting miR-214/RIPK1 through TNF signaling pathway' [Free Radic. Biol. Med. 155 (2020), 69-80].
Song YF, Zhao L, Wang BC, Sun JJ, Hu JL, Zhu XL, Zhao J, Zheng DK, Ge ZW
Free radical biology & medicine. 2021; ():

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites